BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26164481)

  • 21. Out-of-pocket healthcare spending by the poor and chronically ill in the Republic of Korea.
    Ruger JP; Kim HJ
    Am J Public Health; 2007 May; 97(5):804-11. PubMed ID: 17395834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial burden of raising CSHCN: association with state policy choices.
    Parish SL; Shattuck PT; Rose RA
    Pediatrics; 2009 Dec; 124 Suppl 4():S435-42. PubMed ID: 19948610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?
    McIntyre D; Thiede M; Dahlgren G; Whitehead M
    Soc Sci Med; 2006 Feb; 62(4):858-65. PubMed ID: 16099574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the private sector? Understanding private provision in the health systems of low-income and middle-income countries.
    Mackintosh M; Channon A; Karan A; Selvaraj S; Cavagnero E; Zhao H
    Lancet; 2016 Aug; 388(10044):596-605. PubMed ID: 27358253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review.
    Sakeena MHF; Bennett AA; McLachlan AJ
    Int J Antimicrob Agents; 2018 Dec; 52(6):771-782. PubMed ID: 30312654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health Care Expenditure and GDP in Oil Exporting Countries: Evidence From OPEC Data, 1995-2012.
    Fazaeli AA; Ghaderi H; Salehi M; Fazaeli AR
    Glob J Health Sci; 2015 Jun; 8(2):93-8. PubMed ID: 26383195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    Savoldi A; Carrara E; Gladstone BP; Azzini AM; Göpel S; Tacconelli E
    J Antimicrob Chemother; 2019 Dec; 74(12):3619-3625. PubMed ID: 31730162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparities in the financial burden of children's healthcare expenditures.
    Wong ST; Galbraith A; Kim S; Newacheck PW
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1008-13. PubMed ID: 16275788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inequalities in health care use and expenditures: empirical data from eight developing countries and countries in transition.
    Makinen M; Waters H; Rauch M; Almagambetova N; Bitran R; Gilson L; McIntyre D; Pannarunothai S; Prieto AL; Ubilla G; Ram S
    Bull World Health Organ; 2000; 78(1):55-65. PubMed ID: 10686733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of health care financing on family budgets.
    Rasell E; Bernstein J; Tang K
    Int J Health Serv; 1994; 24(4):691-714. PubMed ID: 7896470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Financial protection from health spending in the Philippines: policies and progress.
    Bredenkamp C; Buisman LR
    Health Policy Plan; 2016 Sep; 31(7):919-27. PubMed ID: 27072948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for STD management in developing countries: choice, procurement, cost, and financing.
    Van der Veen F; Fransen L
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S166-74. PubMed ID: 10023369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can public financing of the private sector defeat antimicrobial resistance?
    James JE
    J Public Health (Oxf); 2019 Jun; 41(2):422-426. PubMed ID: 29982521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Out-of-pocket health expenses for Medicaid and other poor and near-poor persons in 1980.
    Howell E; Corder L; Dobson A
    Natl Med Care Util Expend Surv B; 1985 Aug; (4):1-52. PubMed ID: 10313450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in South-East Asia: Results from the ACTION Study.
    ; Jan S; Kimman M; Peters SA; Woodward M
    Surgery; 2015 Jun; 157(6):971-82. PubMed ID: 25934082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India.
    Garg CC; Karan AK
    Health Policy Plan; 2009 Mar; 24(2):116-28. PubMed ID: 19095685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial Burden and Out-of-Pocket Expenditures for Mental Health Across Different Socioeconomic Groups: Results from HealthCare for Communities.
    Ringel JS; Sturm R
    J Ment Health Policy Econ; 2001 Sep; 4(3):141-150. PubMed ID: 11967474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe.
    Cherny NI; Sullivan R; Torode J; Saar M; Eniu A
    Ann Oncol; 2017 Nov; 28(11):2633-2647. PubMed ID: 28950323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Household out-of-pocket medical expenditures and National Health Insurance in Taiwan: income and regional inequality.
    Chu TB; Liu TC; Chen CS; Tsai YW; Chiu WT
    BMC Health Serv Res; 2005 Sep; 5():60. PubMed ID: 16137336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.